Dentistry First, a dental clinic based in Mooloolaba, has announced the enhancement of its primary dental services, offering improved treatment options to patients across the Sunshine Coast. The ...
The Phase I study aims to evaluate BMF-650’s initial efficacy, tolerability and safety. Credit: angellodeco / Shutterstock.com. Biomea Fusion has dosed the first participant in the Phase I trial of ...
SAN CARLOS, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea,” “Biomea Fusion” or the “Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today ...
SAN CARLOS, Calif. - Biomea Fusion, Inc. (NASDAQ:BMEA), currently trading at $1.46 and identified as undervalued by InvestingPro analysis, announced Monday it has dosed the first patient in a Phase I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback